Skip to main content
. 2009 Apr 27;106(19):7939–7944. doi: 10.1073/pnas.0901702106

Fig. 2.

Fig. 2.

Early-treated patients generate and preserve antigen-specific memory B cells. (A) Representative ELISpot analyses. (B and C) Box plot analyses on the measles-specific and gp160-specific spot production in controls and patients with different antiretroviral schedule. (D and E) Percentages of patients responding to measles and HIV-1 gp160 ELISpot among groups. White bars, positive response; gray bars, negative response.